
White House. Trump Orders Boost to U.S. Pharmaceutical Supply Chain Resilience
On August 13, 2025, President Trump signed an executive order to strengthen the U.S. pharmaceutical supply chain by prioritizing domestic production of Active Pharmaceutical Ingredients (APIs) and filling the Strategic Active Pharmaceutical Ingredients Reserve (SAPIR). The order mandates the Department of Health and Human Services’ Assistant Secretary for Preparedness and Response (ASPR) to identify 26…